articleTop 1% cited

NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality

European Journal of Cancer · 2012 · Vol. 48(14) · pp. 2192–2202

Roger Stupp✉(University Hospital of Lausanne)Eric T. Wong(Harvard University Press)Andrew A. Kanner(Tel Aviv Sourasky Medical Center)David Steinberg(Tel Aviv University)Herbert H. Engelhard(University of Illinois Chicago)Volkmar HeideckeEilon D. Kirson(Novocure (United States))Sophie Taillibert(Sorbonne Université)Frank Liebermann(University of Pittsburgh)Vladimír Dbalý(Na Homolce Hospital)Zvi Ram(Tel Aviv Sourasky Medical Center)John L. Villano(University of Illinois Chicago)Nikolai G. RainovUri Weinberg(Novocure (United States))David Schiff(University of Virginia)Lara J. KunschnerJeffrey J. Raizer(Northwestern University)Jérôme Honnorat(Université Claude Bernard Lyon 1)Andrew E. Sloan(University Hospitals of Cleveland)Mark G. Malkin(Medical College of Wisconsin)Joseph LandolfiFranz Payer(University of Graz)H. Maximilian Mehdorn(Christian-Albrechts-Universität zu Kiel)Robert J. Weil(Cleveland Clinic)Susan C. Pannullo(Cornell University)Manfred Westphal(Universität Hamburg)Martin Smrčka(Masaryk University)Lawrence S. ChinH. Kostron(Universität Innsbruck)Silvia Höfer(University of Zurich)Jeffrey N. Bruce(Columbia University)Rees Cosgrove(Tufts University)Nina Paleologous(NorthShore University HealthSystem)Yoram Palti(Novocure (United States))Philip H. Gutin(Memorial Sloan Kettering Cancer Center)

View via DOI Publisher page

Glioma Diagnosis and Treatment Meningioma and schwannoma management Brain Metastases and TreatmentMedicineChemotherapyAdverse effectInternal medicineHazard ratioRashClinical endpointSurgeryRandomized controlled trialOncology

MeSH terms

AdultAgedAged, 80 and overAntineoplastic AgentsBrain NeoplasmsElectric Stimulation TherapyEuropeFemaleGlioblastomaHumansIsraelMagnetic Resonance ImagingMaleMiddle AgedNeoplasm Recurrence, Local